Form 4 Filing for Autolus Therapeutics plc

This Form 4 filing details transactions by reporting owner Rao Madduri Ravin, a director at Autolus Therapeutics plc. On June 29, 2026, Mr. Ravin acquired 31,667 Restricted Share Units (RSUs) with a transaction price of $0.00. These RSUs vest on June 29, 2027. Each RSU represents a contingent right to one American Depositary Share (ADS). Additionally, on the same date, Mr. Ravin acquired 47,500 Share Options (Right to Buy) with a transaction price of $0.00. These options vest in twelve equal monthly installments starting July 29, 2026, and have an exercise price of $1.61 per share. Both transactions were marked as direct ownership. The filing was signed on July 1, 2026.